France – Produits pharmaceutiques – Fourniture de produits radiopharmaceutiques pour le GCS Médecine nucléaire de Beauvais.
AI summary
This tender concerns the supply and delivery of radiopharmaceutical products for the GCS Nuclear Medicine facility in Beauvais. The framework agreement will establish terms for procurement of these specialized medical products required for nuclear medicine diagnostic and therapeutic procedures.
Pharmaceutical distributors or manufacturers specializing in radiopharmaceuticals with proper licensing and regulatory compliance for handling radioactive medical products.
Suppliers must be authorized to distribute radiopharmaceutical products and comply with French and EU pharmaceutical regulations, including quality standards and safety protocols for radioactive materials.
Frequently asked questions
What is this tender about?
This tender concerns the supply and delivery of radiopharmaceutical products for the GCS Nuclear Medicine facility in Beauvais. The framework agreement will establish terms for procurement of these specialized medical products required for nuclear medicine diagnostic and therapeutic procedures.
What are the requirements for suppliers?
Suppliers must be authorized to distribute radiopharmaceutical products and comply with French and EU pharmaceutical regulations, including quality standards and safety protocols for radioactive materials.
What type of company should bid?
Pharmaceutical distributors or manufacturers specializing in radiopharmaceuticals with proper licensing and regulatory compliance for handling radioactive medical products.
Who is the buyer?
The buyer is GCS MEDECINE NUCLEAIRE DE BEAUVAIS.
When does this tender close?
Submissions close on September 25, 2026.
What is the estimated value?
The estimated value is 0 EUR.
Le présent accord-cadre a pour objet la fourniture et livraison de produits radiopharmaceutiques pour le GCS de médecine nucléaire de Beauvais.
FDG (Fluorodesoxyglucose)
F-Choline (Fluorocholine)
F-DOPA (Fluorodopa)
F-PSMA (PSMA Fluoré)
FNa (Fluorure de sodium)
Traceurs plaques amyloïdes
Fluciclovine
- PriceVoir article 8.2 du Règlement de Consultation50%
- QualityValeur Technique : Voir article 8.2 du Règlement de consultation0%
- QualityDéveloppement durable : Voir article 8.2 du Règlement de consultation10%
- PriceVoir article 8.2 du règlement de consultation50%
- QualityValeur technique : Voir article 8.2 du règlement de consultation40%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation10%
- QualityValeur technique du produit: Voir article 8.2 du règlement de consultation6%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation5%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…